Development of nucleic acid agents as pharmaceuticals has always been challenging and is plagued by issues in delivery and potential toxicity. Notwithstanding the challenges, potential high revenues associated with...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)